Trials / Unknown
UnknownNCT05893472
A Study on the Efficacy and Safety of Venetoclax Combined With HAA Regimen in Newly Diagnosed Young AML.
The Second Affiliated Hospital of Kunming Medical University
- Status
- Unknown
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 45 (estimated)
- Sponsor
- ZePing Zhou · Academic / Other
- Sex
- All
- Age
- 16 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the efficacy and safety of the combination of venetoclax and HAA regimen in young, newly diagnosed acute myeloid leukemia patients under the age of 60.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| COMBINATION_PRODUCT | combination of venetoclax and HAA regimen | Using the combination of venetoclax and HAA regimen as induction therapy in young, newly diagnosed adult acute myeloid leukemia patients under the age of 60. |
Timeline
- Start date
- 2023-04-01
- Primary completion
- 2024-04-01
- Completion
- 2024-04-01
- First posted
- 2023-06-08
- Last updated
- 2023-06-08
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05893472. Inclusion in this directory is not an endorsement.